2012
DOI: 10.1016/j.vaccine.2012.07.040
|View full text |Cite
|
Sign up to set email alerts
|

A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
55
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(58 citation statements)
references
References 26 publications
2
55
0
1
Order By: Relevance
“…In previous studies, the investigational DTaP-IPV-HB-PRP-T vaccine has been shown to be safe and immunogenic when administered in a 3-dose primary series schedule at 2, 4, and 6 months (7) and 6, 10, and 14 weeks (10), with or without the administration of a standalone HB vaccine at birth (10)(11)(12)(13). Additionally, a booster dose in the second year of life has been shown to be safe and to elicit an anamnestic response irrespective of HB vaccination at birth (11,14).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…In previous studies, the investigational DTaP-IPV-HB-PRP-T vaccine has been shown to be safe and immunogenic when administered in a 3-dose primary series schedule at 2, 4, and 6 months (7) and 6, 10, and 14 weeks (10), with or without the administration of a standalone HB vaccine at birth (10)(11)(12)(13). Additionally, a booster dose in the second year of life has been shown to be safe and to elicit an anamnestic response irrespective of HB vaccination at birth (11,14).…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, a booster dose in the second year of life has been shown to be safe and to elicit an anamnestic response irrespective of HB vaccination at birth (11,14).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, seroprotective levels against P1, P2, P3 and Hib were reached in ≥98%, ≥95%, ≥97 and ≥91% of cases, respectively . Although there is a limit to the absence of PRN, seroconversion rates for acellular pertussis antigens were ≥90% for PT and ≥82% for FHA . After the booster dose, seroprotection rates with Hexyon were consistently 100% for P1, P2, P3 and Hib .…”
Section: Hexyonmentioning
confidence: 93%
“…Por su parte, las vacunas combinadas ofrecen, con una sola administración, protección frente a un mayor número de enfermedades, lo que favorece el cumplimiento del calendario de vacunación, y además obtienen una mayor aceptación entre los padres por la disminución del número de pinchazos y la simplificación de la pauta 27,28 . Existen 2 vacunas hexavalentes combinadas comercializas en España (Infanrix Hexa ® y Hexyon ® ), y ambas ofrecen una buena inmunogenicidad, eficacia y tolerabilidad frente a los antígenos que contienen: difteria (D), tétanos (T), tos ferina acelular (Pa), HB, polio inactivada (VPI) y Haemophilus influenzae b (Hib) [29][30][31][32] .…”
Section: Vacunas Monovalentes Y Combinadas De Hepatitis Bunclassified